ArticleScience advances2024
Matte surfaces with broadband transparency enabled by highly asymmetric diffusion of white light.
Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Generating vectorial optical fields via surface-wave-excited complex-amplitude metasurfaces.Light, science & applications · 2026Article
- Time-programmable coloration via 3D metastructures for optical encryption.Light, science & applications · 2026Article
- Asymmetric Diffusion Metasurface-Based Lensless Monitoring and Uniform Illumination Systems for Optical Lithography.Research (Washington, D.C.) · 2026Article
- Energy-Controllable Manipulation on Surface Waves and Propagating Waves by Bifunctional Metasurfaces.Nanophotonics (Berlin, Germany) · 2026Article
- Emergent scattering regimes in disordered metasurfaces near critical packing.Nature communications · 2025Article
- Nonlocality-enabled photonic analogies of parallel spaces, wormholes and multiple realities.Nature communications · 2025Article
- Topology in Thermal, Particle, and Plasma Diffusion Metamaterials.Chemical reviews · 2025Review
- High-efficiency radiation beyond the critical angle via phase-gradient antireflection metasurfaces.Nanophotonics (Berlin, Germany) · 2025Article
- Parity Metamaterials and Dynamic Acoustic Mimicry.Research (Washington, D.C.) · 2025Article
- Dewdrop Metasurfaces and Dynamic Control Based on Condensation and Evaporation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Programmable flip-metasurface with dynamically tunable reflection and broadband undistorted transmission.Nanophotonics (Berlin, Germany) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The long-standing paradox between matte appearance and transparency has deprived traditional matte materials of optical transparency. Here, we present a solution to this centuries-old optical conundrum by harnessing the potential of disordered optical metasurfaces. Through the construction of a random array of meta-atoms tailored in asymmetric backgrounds, we have created transparent matte surfaces that maintain clear transparency regardless of the strength of disordered light scattering or their matte appearances. This remarkable property originates in the achievement of highly asymmetric light diffusion, exhibiting substantial diffusion in reflection and negligible diffusion in transmission across the entire visible spectrum. By fabricating macroscopic samples of such metasurfaces through industrial lithography, we have experimentally demonstrated transparent windows camouflaged as traditional matte materials, as well as transparent displays with high clarity, full color, and one-way visibility. Our work introduces an unprecedented frontier of transparent matte materials in optics, offering unprecedented opportunities and applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.